Sertraline Hydrochloride Tablet
Product Images NDC 68071-3951

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 68071-3951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3951 3)

This text appears to be a description of a medication, specifically "Sertraline Hydrochloride 25mg" tablets. It includes details about the NDC numbers, expiration dates, dosage information, tablet appearance, manufacturer, lot numbers, and storage instructions. The text also provides a warning to keep the medication out of reach of children and to store it at a controlled temperature.*

FDA Label Image

Image Description (Struct)

FDA Label Image

Table 3 (Table 3)

FDA Label Image

Table1 (Table1)

This text provides a table indicating the recommended daily dosage of sertraline hydrochloride for patients with various conditions such as Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD). It lists starting doses and therapeutic ranges for adults and pediatric patients in different categories.*

FDA Label Image

Table2 (Table2)

This text outlines the risk differences in the number of cases of suicidal thoughts or behaviors in placebo-controlled trials of antidepressants among pediatric and adult patients of varying age ranges. The data shows an increase in suicidal thoughts or behaviors in patients under 18 years and between 18-24 years, while a decrease is observed in patients between 25-64 years and those aged 65 and older.*

FDA Label Image

Image Description (Table4)

This text provides a list of the most common sexual adverse reactions in men and women from sertraline hydrochloride pooled controlled trials in adults dealing with various conditions. In men, the adverse reactions include ejaculation failure, decreased libido, erectile dysfunction, ejaculation disorder, and male sexual dysfunction. In contrast, for women, the only listed adverse reaction is decreased libido.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.